BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37517208)

  • 1. Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study.
    Hamzah M; Seelhammer TG; Beshish AG; Byrnes J; Yabrodi M; Szadkowski A; Lutfi R; Andrijasevic N; Hock K; Worley S; Macrae DJ
    Thromb Res; 2023 Sep; 229():178-186. PubMed ID: 37517208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
    Diaz D; Martinez J; Bushman G; Wolowich WR
    J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
    Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
    Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.
    Uricchio MN; Ramanan R; Esper SA; Murray H; Kaczorowski DJ; D'Aloiso B; Gomez H; Sciortino C; Sanchez PG; Sappington PL; Rivosecchi RM
    ASAIO J; 2023 Jan; 69(1):107-113. PubMed ID: 35412480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.
    Valdes CA; Sharaf OM; Bleiweis MS; Jacobs JP; Mumtaz M; Sharaf RM; Jeng EI; Peek GJ
    Front Med (Lausanne); 2023; 10():1137134. PubMed ID: 36999064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
    Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
    J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
    Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
    Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
    Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
    Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
    Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
    Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin in pediatric extracorporeal membrane oxygenation.
    Ryerson LM; McMichael ABV
    Curr Opin Pediatr; 2022 Jun; 34(3):255-260. PubMed ID: 35634698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation.
    Frydman GH; Berger BM; Kostousov V; Bruzdovski K; Papageorgiou DP; Navaei A; Hui SR; Teruya J
    Crit Care Explor; 2022 Oct; 4(10):e0776. PubMed ID: 36311559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO
    Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
    Ma M; Liang S; Zhu J; Dai M; Jia Z; Huang H; He Y
    Front Pharmacol; 2022; 13():771563. PubMed ID: 35496287
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
    Hamzah M; Jarden AM; Ezetendu C; Stewart R
    Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.
    Sheridan EA; Sekela ME; Pandya KA; Schadler A; Ather A
    ASAIO J; 2022 Jul; 68(7):920-924. PubMed ID: 34669620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
    Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
    Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
    Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME
    Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.